Science and Research

COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study

Adult PAP patients experience similar #COVID19 rates to the general population, and high rates of hospitalisation and deaths, underscoring their vulnerability and the need for measures to prevent infection. The impact of iGM-CSF must be considered. https://bit.ly/3M0wKnZ.

  • Papiris, S. A.
  • Campo, I.
  • Mariani, F.
  • Kallieri, M.
  • Kolilekas, L.
  • Papaioannou, A. I.
  • Gonca Chousein, E.
  • Cetinkaya, E.
  • Bonella, F.
  • Borie, R.
  • Kokosi, M.
  • Pickworth, T.
  • Molina-Molina, M.
  • Gasa, M.
  • Radzikowska, E.
  • Fijolek, J.
  • Jouneau, S.
  • Gomez, E.
  • McCarthy, C.
  • Bendstrup, E.
  • Piotrowski, W. J.
  • Pabary, R.
  • Hadchouel, A.
  • Coolen-Allou, N.
  • Alfaro, T.
  • Robalo Cordeiro, C.
  • Antonogiannaki, E. M.
  • Tomos, I. P.
  • Papakosta, D.
  • Kontakiotis, T.
  • Panagiotou, P.
  • Douros, K.
  • Schams, A.
  • Lettieri, S.
  • Papaevangelou, V.
  • Kanaka-Gantenbein, C.
  • Karakatsani, A.
  • Loukides, S.
  • Costabel, U.
  • Crestani, B.
  • Morgan, C.
  • Tazawa, R.
  • Bush, A.
  • Griese, M.
  • Manali, E. D.
Publication details
DOI: 10.1183/23120541.00199-2022
Journal: ERJ Open Res
Number: 1
Work Type: Original
Location: CPC-M
Disease Area: PALI, DPLD
Partner / Member: KUM
Access-Number: 36601310

DZL Engagements

chevron-down